JP2001503755A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2001503755A5 JP2001503755A5 JP1998521140A JP52114098A JP2001503755A5 JP 2001503755 A5 JP2001503755 A5 JP 2001503755A5 JP 1998521140 A JP1998521140 A JP 1998521140A JP 52114098 A JP52114098 A JP 52114098A JP 2001503755 A5 JP2001503755 A5 JP 2001503755A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9622852.3 | 1996-11-01 | ||
| GBGB9622852.3A GB9622852D0 (en) | 1996-11-01 | 1996-11-01 | Treatment of intimal hyperplasma |
| GBGB9709494.0A GB9709494D0 (en) | 1997-05-09 | 1997-05-09 | Delivery device and method |
| GB9709494.0 | 1997-05-09 | ||
| GBGB9717791.9A GB9717791D0 (en) | 1997-08-21 | 1997-08-21 | Treatment of intimal hyperplasia |
| GB9717791.9 | 1997-08-21 | ||
| PCT/GB1997/003015 WO1998020027A2 (en) | 1996-11-01 | 1997-11-03 | Therapeutic use of an agent that stimulates no or prostacyclin production and delivery device |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008004349A Division JP4783797B2 (ja) | 1996-11-01 | 2008-01-11 | Ｎｏまたはプロスタサイクリン産生を刺激する薬剤の治療的使用および送達装置 |
| JP2011236266A Division JP2012031196A (ja) | 1996-11-01 | 2011-10-27 | Ｎｏまたはプロスタサイクリン産生を刺激する薬剤の治療的使用および送達装置 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2001503755A JP2001503755A (ja) | 2001-03-21 |
| JP2001503755A5 true JP2001503755A5 (enExample) | 2005-06-16 |
Family
ID=27268562
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP52114098A Withdrawn JP2001503755A (ja) | 1996-11-01 | 1997-11-03 | Ｎｏまたはプロスタサイクリン産生を刺激する薬剤の治療的使用およびデリバリー装置 |
| JP2008004349A Expired - Fee Related JP4783797B2 (ja) | 1996-11-01 | 2008-01-11 | Ｎｏまたはプロスタサイクリン産生を刺激する薬剤の治療的使用および送達装置 |
| JP2011236266A Pending JP2012031196A (ja) | 1996-11-01 | 2011-10-27 | Ｎｏまたはプロスタサイクリン産生を刺激する薬剤の治療的使用および送達装置 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008004349A Expired - Fee Related JP4783797B2 (ja) | 1996-11-01 | 2008-01-11 | Ｎｏまたはプロスタサイクリン産生を刺激する薬剤の治療的使用および送達装置 |
| JP2011236266A Pending JP2012031196A (ja) | 1996-11-01 | 2011-10-27 | Ｎｏまたはプロスタサイクリン産生を刺激する薬剤の治療的使用および送達装置 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US7320679B2 (enExample) |
| EP (2) | EP1488761A1 (enExample) |
| JP (3) | JP2001503755A (enExample) |
| KR (1) | KR100695590B1 (enExample) |
| AT (1) | ATE287271T1 (enExample) |
| AU (1) | AU729420B2 (enExample) |
| CA (1) | CA2270286C (enExample) |
| DE (1) | DE69732304T2 (enExample) |
| ES (1) | ES2235227T3 (enExample) |
| HU (1) | HU223957B1 (enExample) |
| NO (1) | NO326303B1 (enExample) |
| PL (1) | PL189744B1 (enExample) |
| PT (1) | PT941116E (enExample) |
| WO (1) | WO1998020027A2 (enExample) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7727761B2 (en) | 1995-08-01 | 2010-06-01 | Vegenics Limited | Vascular endothelial growth factor C (VEGF-C) protein and gene, mutants thereof, and uses thereof |
| US20080305999A1 (en) * | 1996-11-01 | 2008-12-11 | John Francis Martin | Therapeutic use of growth factor, and delivery device, especially for the treatment of intimal hyperplasia |
| EP1019082B2 (en) | 1997-10-02 | 2008-06-04 | Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E.V. | Use of a colony stimulating factor (csf) for enhancing collateral growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| GB9809082D0 (en) | 1998-04-28 | 1998-06-24 | Eurogene Limited | Delivery device |
| ATE253934T1 (de) * | 1998-09-09 | 2003-11-15 | Scios Inc | Verwendung eines angiogenen faktors zur behandlung von mikrovaskulären angiopathien |
| US6596699B2 (en) | 1998-09-22 | 2003-07-22 | Biosurface Engineering Technologies, Inc. | Nucleic acid coating compositions and methods |
| US6958147B1 (en) | 1998-10-26 | 2005-10-25 | Licentia Ltd | Use of VEGF-C to prevent restenosis |
| FR2792531B1 (fr) * | 1999-04-26 | 2003-01-31 | Aventis Pharma Sa | Utilisation d'adenovirus recombinant defectif comprenant un acide nucleique codant pour un facteur angiogenique pour le traitement de l'hypertension arterielle pulmonaire |
| HUP0200961A3 (en) * | 1999-04-26 | 2004-11-29 | Inst Nat Sante Rech Med | Use of a recombinant defective adenovirus comprising a nucleic acid encoding an angiogenic factor for treating pulmonary hypertension |
| ATE364387T1 (de) * | 1999-09-23 | 2007-07-15 | An Go Gen Inc | Zellbasierte gentherapie für das lungensystem |
| JP2003513105A (ja) * | 1999-11-02 | 2003-04-08 | ジェネンテック・インコーポレーテッド | ｅＮＯＳ活性の調節とその治療的使用 |
| US7078382B1 (en) | 1999-11-02 | 2006-07-18 | Genentech, Inc. | Modulation of eNOS activity and therapeutic uses thereof |
| SE0000285D0 (sv) * | 1999-12-07 | 2000-01-31 | Mika Lahtinen | Medical implant |
| AU3988401A (en) | 2000-02-25 | 2001-09-03 | Ludwig Inst Cancer Res | Materials and methods involving hybrid vascular endothelial growth factor dnas and proteins |
| GB0012997D0 (en) * | 2000-05-26 | 2000-07-19 | Eurogene Limited | Gene delivery |
| WO2002096469A2 (en) * | 2001-05-29 | 2002-12-05 | Ark Therapeutics Ltd. | Gene delivery via a baculovirus vector |
| EP1406559A1 (en) * | 2001-07-06 | 2004-04-14 | Tricardia, L.L.C. | Anti-arrhythmia devices and methods of use |
| SE0102578L (sv) * | 2001-07-20 | 2003-01-21 | Oeyvind Reitan | Förändring av en stents egenskaper för att förhindra restenos |
| CA2526643A1 (en) * | 2003-06-18 | 2004-12-29 | Georg-August-Universitat Gottingen | Use of a vegf receptor gene or gene product |
| GB0515140D0 (en) * | 2005-07-22 | 2005-08-31 | Ark Therapeutics Ltd | Therapeutic device |
| ES2363758T3 (es) | 2005-08-15 | 2011-08-16 | Vegenics Pty Ltd | Vegf y pdgf modificados con propiedades angiogénicas mejoradas. |
| JP2009523807A (ja) * | 2006-01-18 | 2009-06-25 | ザ ジェネラル ホスピタル コーポレイション | リンパ機能を高める方法 |
| US8721711B2 (en) | 2007-06-20 | 2014-05-13 | Oregon Health & Science University | Graft having microporous membrane for uniform fluid infusion |
| CA2746807A1 (en) * | 2007-12-14 | 2009-06-25 | Oregon Health & Science University | Drug delivery cuff |
| DE102008002396A1 (de) * | 2008-06-12 | 2009-12-17 | Biotronik Vi Patent Ag | Implantierbares Wirkstoffreservoir und Vorrichtung mit einem implantierbaren Wirkstoffreservoir |
| JP6562632B2 (ja) * | 2012-02-14 | 2019-08-21 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 心血管疾患および他の状態のためのパラクリン遺伝子の全身送達および制御された発現 |
| WO2013135266A1 (en) | 2012-03-12 | 2013-09-19 | Gemvax As | Treatment of non-small cell lung carcinoma by active immunotherapy |
| CN104684561A (zh) | 2012-08-01 | 2015-06-03 | 联合治疗公司 | 利用间充质干细胞的肺动脉高血压的治疗 |
| KR102466885B1 (ko) | 2013-01-09 | 2022-11-11 | 유나이티드 세러퓨틱스 코오포레이션 | 프로스타시클린 및 중간엽 줄기 세포를 사용한 혈관병증의 치료 |
| JP7179723B2 (ja) | 2016-10-24 | 2022-11-29 | ユナイテッド セラピューティクス コーポレイション | トレプロスチニルによるｍｓｃの免疫調節特性の増強 |
| CN114040923B (zh) * | 2019-04-05 | 2024-11-26 | 韩国窑业技术院 | 利用肌集钙蛋白标签的蛋白质的表达及纯化方法 |
| IT201900012537A1 (it) * | 2019-07-22 | 2021-01-22 | Milano Politecnico | Dispositivo di condizionamento per condizionare un tratto esposto di un vaso sanguigno e metodo |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3797485A (en) * | 1971-03-26 | 1974-03-19 | Alza Corp | Novel drug delivery device for administering drug into blood circulation in blood vessel |
| JPS56122317A (en) * | 1980-02-29 | 1981-09-25 | Koken:Kk | Drug transporting material and its preparation |
| US5326568A (en) * | 1991-05-03 | 1994-07-05 | Giampapa Vincent C | Method of tissue-specific delivery |
| US5201728A (en) * | 1991-05-03 | 1993-04-13 | Giampapa Vincent C | Subcutaneous implantable multiple-agent delivery system |
| US5399352A (en) * | 1993-04-14 | 1995-03-21 | Emory University | Device for local drug delivery and methods for using the same |
| EP0702518B1 (en) * | 1993-06-11 | 2003-04-02 | The Board Of Trustees Of The Leland Stanford Junior University | Treatment of vascular degenerative diseases by modulation of endogenous nitric oxide production or activity |
| US5653744A (en) * | 1995-04-27 | 1997-08-05 | Khouri Biomedical Research, Inc. | Device and method for vascular anastomosis |
| US5830879A (en) * | 1995-10-02 | 1998-11-03 | St. Elizabeth's Medical Center Of Boston, Inc. | Treatment of vascular injury using vascular endothelial growth factor |
-
1997
- 1997-11-03 AU AU47906/97A patent/AU729420B2/en not_active Ceased
- 1997-11-03 EP EP04021613A patent/EP1488761A1/en not_active Withdrawn
- 1997-11-03 ES ES97910563T patent/ES2235227T3/es not_active Expired - Lifetime
- 1997-11-03 HU HU9902867A patent/HU223957B1/hu not_active IP Right Cessation
- 1997-11-03 PL PL97333272A patent/PL189744B1/pl not_active IP Right Cessation
- 1997-11-03 AT AT97910563T patent/ATE287271T1/de active
- 1997-11-03 CA CA002270286A patent/CA2270286C/en not_active Expired - Fee Related
- 1997-11-03 DE DE69732304T patent/DE69732304T2/de not_active Expired - Lifetime
- 1997-11-03 KR KR1019997003881A patent/KR100695590B1/ko not_active Expired - Fee Related
- 1997-11-03 EP EP97910563A patent/EP0941116B1/en not_active Expired - Lifetime
- 1997-11-03 PT PT97910563T patent/PT941116E/pt unknown
- 1997-11-03 JP JP52114098A patent/JP2001503755A/ja not_active Withdrawn
- 1997-11-03 WO PCT/GB1997/003015 patent/WO1998020027A2/en not_active Ceased
-
1999
- 1999-04-30 NO NO19992106A patent/NO326303B1/no not_active IP Right Cessation
-
2003
- 2003-02-19 US US10/370,291 patent/US7320679B2/en not_active Expired - Fee Related
-
2008
- 2008-01-11 JP JP2008004349A patent/JP4783797B2/ja not_active Expired - Fee Related
-
2011
- 2011-10-27 JP JP2011236266A patent/JP2012031196A/ja active Pending